GCM
NRC icon

Gladius Capital Management’s NRC Health Common Stock NRC Stock Holding History

Gladius Capital Management’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,068
Closed -$70.1K – 189
2024
Q3 		$70.1K Buy
3,068
+1,908
+164% +$43.1K 0.01% 139
2024
Q2 		$26.6K Sell
1,160
-212
-15% -$6.54K ﹤0.01% 292
2024
Q1 		$54.3K Buy
1,372
+46
+3% +$1.82K 0.02% 171
2023
Q4 		$52.5K Buy
1,326
+496
+60% +$20.8K 0.01% 172
2023
Q3 		$36.8K Buy
830
+237
+40% +$10.3K ﹤0.01% 243
2023
Q2 		$25.8K Sell
593
-204
-26% -$8.97K ﹤0.01% 280
2023
Q1 		$34.7K Sell
797
-186
-19% -$8.21K ﹤0.01% 257
2022
Q4 		$36.7K Buy
+983
New +$38K ﹤0.01% 251

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gladius Capital Management's NRC Position: Q4 2024 in Review

Gladius Capital Management sold out of NRC Health Common Stock (NRC) in Q4 2024, closing a stake of 3,068 shares — an estimated $70.1K sold.

Gladius Capital Management first reported a position in NRC in Q4 2022 and held it in 8 quarters. The position peaked at $70.1K in Q3 2024. 133 funds tracked by Wall St. Rank hold NRC as of Q4 2024.

  • Gladius Capital Management reported no remaining NRC Health Common Stock position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 3,068 NRC Health Common Stock shares in Q4 2024, an estimated $70.1K.
  • Gladius Capital Management first reported a position in NRC Health Common Stock in Q4 2022 and held it in 8 quarters.
  • Gladius Capital Management's NRC Health Common Stock position peaked at $70.1K in Q3 2024.
  • 133 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.